{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Protocols of conversion from cyclosporin A ( CsA ) to sirolimus ( SRL ) have been widely used in immunotherapy after transplantation to prevent CsA - induced nephropathy , but the molecular mechanisms underlying these protocols remain nuclear .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| cyclosporin A (CsA) - induced nephropathy |\n\nExplanation:\n\n1. cyclosporin A (CsA) - induced nephropathy: This is a disease entity, as it refers to a specific medical condition where nephropathy (kidney disease) is caused by the administration of cyclosporin A (CsA), an immunosuppressant drug used in transplantation."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| cyclosporin A (CsA) - induced nephropathy |\n\nExplanation:\n\n1. cyclosporin A (CsA) - induced nephropathy: This is the only clear disease entity in the paragraph. It refers to a specific medical condition where nephropathy (kidney disease) is caused by the administration of cyclosporin A (CsA), an immunosuppressant drug used in transplantation. The other terms in the paragraph, such as immunotherapy and transplantation, are medical procedures or treatments, not diseases."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Protocols of conversion from cyclosporin A ( CsA ) to sirolimus ( SRL ) have been widely used in immunotherapy after transplantation to prevent CsA - induced nephropathy , but the molecular mechanisms underlying these protocols remain nuclear .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| cyclosporin A |\n| CsA |\n| sirolimus |\n| SRL |\n\nExplanation:\n\n1. cyclosporin A\n2. CsA (which is an abbreviation for cyclosporin A)\n3. sirolimus\n4. SRL (which is an abbreviation for sirolimus)\n\nThese are the chemical entities present in the given paragraph. They are mentioned precisely in the same words as in the original paragraph."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| cyclosporin A |\n| sirolimus |\n\nExplanation:\n\n1. cyclosporin A\n2. sirolimus\n\nThese are the chemical entities present in the given paragraph. I have removed \"CsA\" and \"SRL\" as they are abbreviations for the chemical entities \"cyclosporin A\" and \"sirolimus\" respectively, and are not clear chemical entities on their own. The entities are presented precisely in the same words as in the original paragraph."}
  ]
}